SynuSight Biotech has licensed 18 F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment . SHANGH ...
Scientists outline the scientific and technical case for building a northern-hemisphere 30-meter telescope at La Palma to support time-domain and multi-messenger astronomy.
SynuSight Biotech ("SynuSight"), a biotechnology company dedicated to the development of diagnostic solutions for neurodegenerative diseases and ABLi Therapeutics ("ABLi"), a biotechnology company ...
Morning Overview on MSN
5 beginner telescope mistakes and how to fix them fast
Getting your first telescope should feel exciting, not frustrating. If I avoid a few common beginner mistakes, I can turn ...
Astronomy on MSN
The evolution of solar imaging
The Sun has captivated humanity for millennia. And yet, despite being our closest star, studying it is not easy. Its blinding ...
The glasses are the same concept as Xreal's other models, but the flatter lens design and 57-degree field of view are the same as the One Pros. The 240Hz refresh rate is new, and trying the glasses ...
Two related discoveries detailing nanocrystalline mineral formation and dynamics have broad implications for managing nuclear ...
At CES 2026, Xreal announced an upgraded, slightly more affordable version of its entry-level AR glasses: the $449 Xreal 1S.
A simple software method to increase the duty-cycle resolution in a digital pulse width modulation (DPWM)-controlled power ...
Collagen is the most abundant protein in the human body and has an important role in healthy tissue as well as in a range of prevalent diseases. Medical research and diagnostics hence call for means ...
Lithium-rich layered oxides (LRLOs) offer exceptionally high capacities but suffer rapid energy loss because of irreversible ...
Astronomers have obtained the sharpest-ever X-ray spectrum of an iconic active galaxy, providing the most accurate, precise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results